Publications by authors named "E Fabbro"

Cancer-related neuropathic pain (CRNP) is often a significant burden on patients' quality of life. There are limited treatment guidelines for cancer-related neuropathic pain outside of CIPN. Although opioids are considered a third-line treatment option, no consensus exists on which opioid is most effective, either as a single agent or in combination with other medications.

View Article and Find Full Text PDF

A self-reported electronic questionnaire to advocate for a consensus definition of nutrition impact symptoms (NISs) was conducted in a diverse group of international healthcare providers. The questionnaire had 2 components: the definition of NISs and the relevance of each symptom as a NIS. Agreement on the tentative definition and 24 symptoms were evaluated using a seven-point Likert scale.

View Article and Find Full Text PDF

Purpose Of Review: The following review will highlight the development of anamorelin to treat cancer anorexia-cachexia syndrome (CACS) including the potential benefits, limitations, and future directions.

Recent Findings: Ghrelin, a 28-amino acid peptide hormone, is secreted by the stomach mucosa and regulates appetite, promotes lipogenesis, increases body weight, improves gastric motility, reduces catabolic wasting and inflammation. Several randomized, double-blind, placebo-controlled clinical trials evaluating anamorelin, a ghrelin agonist, for the treatment of CACS have reported improvement in appetite and body composition including both lean body and fat mass; however, most studies noted no improvement in physical function as assessed by measuring non-dominant hand-grip strength.

View Article and Find Full Text PDF
Article Synopsis
  • Cancer cachexia (CC) is often overlooked and poorly treated, despite advancements in understanding its causes and potential interventions, leading to issues like fatigue, lower quality of life, and reduced survival rates.
  • Key aspects like weight loss and appetite decline should be detected early; managing underlying conditions and nutritional challenges, along with pharmacological options like progesterone analogs and corticosteroids, are recommended for treatment.
  • Innovative drugs, such as Anamorelin in Japan, show promise in improving symptoms of CC, and future strategies may involve a combination of therapies alongside exercise and nutrition to enhance treatment effectiveness.
View Article and Find Full Text PDF

This study investigates the complex interplay among innovation, research and development (R&D), and entrepreneurship within the context of European nations. The focus of the study is also on the contributory role of tertiary educational institutions in nurturing entrepreneurial activities. To deepen the understanding of these multifaceted relationships and their subsequent impact on regional economies, the research introduces a novel metric termed the Innovation Readiness Environment (IRE) index.

View Article and Find Full Text PDF